SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-090137
Filing Date
2024-08-15
Accepted
2024-08-15 16:30:06
Documents
1
Group Members
NOVARTIS BIDCO AGNOVARTIS BIDCO GERMANY AGNOVARTIS PHARMA AG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2410988d41_sc13da.htm SC 13D/A 99427
  Complete submission text file 0001104659-24-090137.txt   101187
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Subject) CIK: 0001340243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90872 | Film No.: 241212828
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)